After a total of six courses of chemotherapy and radiotherapy, follow-up CT and magnetic resonance imaging (MRI) showed residual tumor but a decrease in size of the lung, liver, retroperitoneal lymph node and brain tumors (Figure 1D-F) as well as a decrease in tumor markers (LDH: 174 U/l, AFP: 2.30 ng/ml, and b-HCG: 473.80 mIU/ml; Figure-2). The gene discussed is AFP; the disease is neoplasm.